Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2804)
All Articles published online
|
Nov 7, 2005 (publication date) through May 6, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Lu B, Chen MT, Fan YH, Liu Y, Meng LN. Effects of |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i41/6518.htm |
| Number | Citing Articles |
| 1 |
S. A. V. Nieuwenburg, M. C. Mommersteeg, E. L. Eikenboom, B. Yu, W. J. den Hollander, I. Lisanne Holster, Caroline M. den Hoed, L. G Capelle, Thjon J. Tang, Marie-Paule Anten, I. Prytz-Berset, E. M. Witteman, F. ter Borg, Jordy P. W. Burger, Marco J. Bruno, G. M. Fuhler, Maikel P. Peppelenbosch, Michael Doukas, Ernst J. Kuipers, Manon C.W. Spaander. Factors associated with the progression of gastric intestinal metaplasia: a multicenter, prospective cohort study. Endoscopy International Open 2021; 9(03): E297 doi: 10.1055/a-1314-6626
|
| 2 |
Y.‐J. Hwang, N. Kim, H. S. Lee, J. B. Lee, Y. J. Choi, H. Yoon, C. M. Shin, Y. S. Park, D. H. Lee. Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication ‐ a prospective study for up to 10 years. Alimentary Pharmacology & Therapeutics 2018; 47(3): 380 doi: 10.1111/apt.14424
|
| 3 |
Andrew J. Gawron, Shailja C. Shah, Osama Altayar, Perica Davitkov, Douglas Morgan, Kevin Turner, Reem A. Mustafa. AGA Technical Review on Gastric Intestinal Metaplasia—Natural History and Clinical Outcomes. Gastroenterology 2020; 158(3): 705 doi: 10.1053/j.gastro.2019.12.001
|
| 4 |
Constantin Hays, Thibault Delerue, Dominique Lamarque, Christophe Burucoa, Ghislaine Collobert, Annick Billöet, Nicolas Kalach, Josette Raymond. Molecular diagnosis of Helicobacter pylori infection in gastric biopsies: Evaluation of the Amplidiag®H. pylori + ClariR assay. Helicobacter 2019; 24(2) doi: 10.1111/hel.12560
|
| 5 |
JiHyung Nam, KumHei Ryu, BumJoon Park, ChanWha Lee, Eun-Cheol Park. Rate and predictive factors of Helicobacter pylori recurrence: Analysis of a screening cohort. Saudi Journal of Gastroenterology 2019; 25(4): 251 doi: 10.4103/sjg.SJG_456_18
|
| 6 |
D. Lamarque. Faut-il surveiller la métaplasie intestinale et la dysplasie dans l’estomac ?. Acta Endoscopica 2012; 42(5): 257 doi: 10.1007/s10190-012-0281-1
|
| 7 |
Chun-Yan Weng, Jing-Li Xu, Shao-Peng Sun, Kai-Jie Wang, Bin Lv. <i>Helicobacter pylori </i>eradication: Exploring its impacts on the gastric mucosa. World Journal of Gastroenterology 2021; 27(31): 5152-5170 doi: 10.3748/wjg.v27.i31.5152
|
| 8 |
Chang Mo Moon, Seok-Hyung Kim, Sang Kil Lee, Jiyeon Hyeon, Ja Seung Koo, Sangheun Lee, Jean S. Wang, Won Jae Huh, Shradha S. Khurana, Jason C. Mills. Chronic Tamoxifen Use Is Associated with a Decreased Risk of Intestinal Metaplasia in Human Gastric Epithelium. Digestive Diseases and Sciences 2014; 59(6): 1244 doi: 10.1007/s10620-013-2994-1
|
| 9 |
Judite Dietz, Jane Maria Ulbrich-Kulcynski, Katia Elisabete Pires Souto, Nelson Guardiola Meinhardt. Prevalence of upper digestive endoscopy and gastric histopathology findings in morbidly obese patients. Arquivos de Gastroenterologia 2012; 49(1): 52 doi: 10.1590/S0004-28032012000100009
|
| 10 |
Kichul Yoon, Nayoung Kim. Reversibility of Atrophic Gastritis and Intestinal Metaplasia by Eradication ofHelicobacter pylori. The Korean Journal of Gastroenterology 2018; 72(3): 104 doi: 10.4166/kjg.2018.72.3.104
|
| 11 |
Nozomi Yokota, Ryusuke Ae, Masaki Amenomori, Koji Kitagawa, Takuya Nakamura, Tetsuro Yokota, Kato Masato, Teppei Sasahara, Yuri Matsubara, Koki Kosami, Yoshikazu Nakamura. Clinical background factors affecting outcomes of Helicobacter pylori eradication therapy in primary care. Journal of General and Family Medicine 2019; 20(4): 139 doi: 10.1002/jgf2.245
|
| 12 |
B. R. Achyut, N. Moorchung, B. Mittal. Genetic association of interleukin-1 haplotypes with gastritis and precancerous lesions in North Indians. Clinical and Experimental Medicine 2008; 8(1): 23 doi: 10.1007/s10238-008-0152-4
|
| 13 |
|
| 14 |
Hamza Olleik, Elias Baydoun, Josette Perrier, Akram Hijazi, Josette Raymond, Marine Manzoni, Lucas Dupuis, Ghislain Pauleau, Yvain Goudard, Bruno de La Villéon, Géraldine Goin, Philippe Sockeel, Muhammad Iqbal Choudhary, Eric Di Pasquale, Muhammad Nadeem-ul-Haque, Hunain Ali, Arif Iftikhar Khan, Farzana Shaheen, Marc Maresca. Temporin-SHa and Its Analogs as Potential Candidates for the Treatment of Helicobacter pylori. Biomolecules 2019; 9(10): 598 doi: 10.3390/biom9100598
|
| 15 |
Yo Han Park, Nayoung Kim. Review of Atrophic Gastritis and Intestinal Metaplasia as a Premalignant Lesion of Gastric Cancer. Journal of Cancer Prevention 2015; 20(1): 25 doi: 10.15430/JCP.2015.20.1.25
|
| 16 |
Fangyuan Zhu, Xiaoze Zhang, Ping Li, Yaodong Zhu. Effect of Helicobacter pylori eradication on gastric precancerous lesions: A systematic review and meta‐analysis. Helicobacter 2023; 28(6) doi: 10.1111/hel.13013
|
| 17 |
Jung Mook Kang, Nayoung Kim, Ji Youn Yoo, Young Soo Park, Dong Ho Lee, Hyun Young Kim, Hye Seung Lee, Gheeyoung Choe, Joo Sung Kim, Hyun Chae Jung, In Sung Song. The Role of Serum Pepsinogen and Gastrin Test for the Detection of Gastric Cancer in Korea. Helicobacter 2008; 13(2): 146 doi: 10.1111/j.1523-5378.2008.00592.x
|
| 18 |
Tian-Tian Sun, Ji-Lin Wang, Jing-Yuan Fang. Quality of RCTs exploringHelicobacter pylorieradication for the prevention of gastric cancer and preneoplastic lesions. Expert Review of Anticancer Therapy 2011; 11(10): 1509 doi: 10.1586/era.11.124
|
| 19 |
Sang Gyun Kim, Hye-Kyung Jung, Hang Lak Lee, Jae Young Jang, Hyuk Lee, Chan Gyoo Kim, Woon Geon Shin, Ein Soon Shin, Yong Chan Lee. Guidelines for the Diagnosis and Treatment ofHelicobacter pyloriInfection in Korea, 2013 Revised Edition. The Korean Journal of Gastroenterology 2013; 62(1): 3 doi: 10.4166/kjg.2013.62.1.3
|
| 20 |
Yongqiang Liang, Yuanhai Yang, Ruiheng Nong, Hao Huang, Xiuyun Chen, Ying Deng, Zhicong Huang, Jingyao Huang, Chunsheng Cheng, Mingzhu Ji, Yinggang Chen, Fulan Hu. Do atrophic gastritis and intestinal metaplasia reverse after Helicobacter pylori eradication?. Helicobacter 2024; 29(1) doi: 10.1111/hel.13042
|
| 21 |
Zhou Liya, Lin Sanren, Ding Shigang, Huang Xuebiao, Jin Zhu, Cui Rongli, Meng Lingmei, Li Yuan, Zhang Li, Guo Changji, Xue Yan, Yan Xiu'e, Zhang Jing. Relationship of Helicobacter pylori eradication with gastric cancer and gastric mucosal histological changes: a 10-year follow-up study. Chinese Medical Journal 2014; 127(8): 1454 doi: 10.3760/cma.j.issn.0366-6999.20132494
|
| 22 |
B.R. Achyut, Uday C. Ghoshal, Nikhil Moorchung, Balraj Mittal. Association of Toll-like receptor–4 (Asp299Gly and Thr399Ileu) gene polymorphisms with gastritis and precancerous lesions. Human Immunology 2007; 68(11): 901 doi: 10.1016/j.humimm.2007.10.006
|
| 23 |
|
| 24 |
Masahiro Asaka, Mototsugu Kato, Shin‐ichi Takahashi, Yoshihiro Fukuda, Toshiro Sugiyama, Hiroyoshi Ota, Naomi Uemura, Kazunari Murakami, Kiichi Satoh, Kentaro Sugano. Guidelines for the Management ofHelicobacter pyloriInfection in Japan: 2009 Revised Edition. Helicobacter 2010; 15(1): 1 doi: 10.1111/j.1523-5378.2009.00738.x
|
| 25 |
Josette Raymond, Jean Michel Thiberge, Catherine Dauga. Diagnosis ofHelicobacter pylorirecurrence: relapse or reinfection? Usefulness of molecular tools. Scandinavian Journal of Gastroenterology 2016; 51(6): 672 doi: 10.3109/00365521.2015.1132338
|
| 26 |
Hang Yang, Xinyue Zhou, Bing Hu. The ‘reversibility’ of chronic atrophic gastritis after the eradication ofHelicobacter pylori. Postgraduate Medicine 2022; 134(5): 474 doi: 10.1080/00325481.2022.2063604
|
| 27 |
Lucy Vannella, Edith Lahner, Cesare Bordi, Emanuela Pilozzi, Emilio Di Giulio, Vito D. Corleto, John Osborn, Gianfranco Delle Fave, Bruno Annibale. Reversal of atrophic body gastritis after H. pylori eradication at long-term follow-up. Digestive and Liver Disease 2011; 43(4): 295 doi: 10.1016/j.dld.2010.10.012
|
| 28 |
Theodoros Rokkas, Dimitios Pistiolas, Panos Sechopoulos, Ioannis Robotis, Georgios Margantinis. The Long‐term Impact of Helicobacter pylori Eradication on Gastric Histology: a Systematic Review and Meta‐analysis. Helicobacter 2007; 12(s2): 32 doi: 10.1111/j.1523-5378.2007.00563.x
|
| 29 |
Sang Gyun Kim, Hye‐Kyung Jung, Hang Lak Lee, Jae Young Jang, Hyuk Lee, Chan Gyoo Kim, Woon Geon Shin, Ein Soon Shin, Yong Chan Lee. Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition. Journal of Gastroenterology and Hepatology 2014; 29(7): 1371 doi: 10.1111/jgh.12607
|
| 30 |
Si Hyung Lee, Byung Ik Jang. Intestinal Metaplasia: Reversible after Treatment?. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2013; 13(2): 91 doi: 10.7704/kjhugr.2013.13.2.91
|
| 31 |
双双 张. Research Progress of Helicobacter pylori in Reversing Gastric Precancerous Lesions. Advances in Clinical Medicine 2018; 8(08): 673 doi: 10.12677/ACM.2018.88113
|
| 32 |
Yuying Cai, Caixia Wang, Zhenghong Chen, Zhengzheng Xu, Huanjie Li, Wenjuan Li, Yundong Sun. Transporters HP0939, HP0497, and HP0471 participate in intrinsic multidrug resistance and biofilm formation in Helicobacter pylori by enhancing drug efflux. Helicobacter 2020; 25(4) doi: 10.1111/hel.12715
|
| 33 |
K. Mönkemüller, H. Neumann, L. C. Fry, P. Malfertheiner. Pathogenesis and Clinical Practice in Gastroenterology. 2008; 160: 33 doi: 10.1007/978-1-4020-8767-7_5
|
| 34 |
Tatsuya Toyokawa, Kin‐ichiro Suwaki, Yasuhiro Miyake, Morihito Nakatsu, Masaharu Ando. Eradication of Helicobacter pylori infection improved gastric mucosal atrophy and prevented progression of intestinal metaplasia, especially in the elderly population: A long‐term prospective cohort study. Journal of Gastroenterology and Hepatology 2010; 25(3): 544 doi: 10.1111/j.1440-1746.2009.05995.x
|
| 35 |
K. Mönkemüller, L. Fry, P. Malfertheiner. Magenkarzinom – eine Infektionskrankheit. Der Gastroenterologe 2006; 1(4): 272 doi: 10.1007/s11377-006-0046-5
|
| 36 |
Sun‐Young Lee. Future candidates for indications of Helicobacter pylori eradication: Do the indications need to be revised?. Journal of Gastroenterology and Hepatology 2012; 27(2): 200 doi: 10.1111/j.1440-1746.2011.06961.x
|
| 37 |
Yasuhiro Wada, Masaaki Kodama, Kazuhiro Mizukami, Tadayoshi Okimoto, Takafumi Fuchino, Koshiro Tsutsumi, Masahide Fukuda, Yuka Hirashita, Kensuke Fukuda, Kazuhisa Okamoto, Ryo Ogawa, Ryoji Kushima, Kazunari Murakami. Differences in Regression Patterns of Complete and Incomplete Intestinal Metaplasia at Ten Years after <i>Helicobacter pylori</i> Eradication. ACTA HISTOCHEMICA ET CYTOCHEMICA 2021; 54(6): 185 doi: 10.1267/ahc.21-00069
|
| 38 |
Hang Yang, Yi Mou, Bing Hu. Discussion on the common controversies of Helicobacter pylori infection. Helicobacter 2023; 28(1) doi: 10.1111/hel.12938
|
| 39 |
Tae Ho Kim, Sok Won Han. Atrophic Gastritis: Reversible after Treatment?. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2013; 13(1): 25 doi: 10.7704/kjhugr.2013.13.1.25
|
| 40 |
Antonella Gallo, Simona Pellegrino, Erika Pero, Maria Chiara Agnitelli, Caterina Parlangeli, Francesco Landi, Massimo Montalto. Main Disorders of Gastrointestinal Tract in Older People: An Overview. Gastrointestinal Disorders 2024; 6(1): 313 doi: 10.3390/gidisord6010022
|
| 41 |
Jan Drnovsek, Matjaz Homan, Nina Zidar, Lojze M Smid. Pathogenesis and potential reversibility of intestinal metaplasia − a milestone in gastric carcinogenesis. Radiology and Oncology 2024; 0(0) doi: 10.2478/raon-2024-0028
|